Davis Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Davis Capital Management's AMGN Position: Q3 2026 in Review
Davis Capital Management reduced its Amgen (AMGN) stake by 6.1% in Q3 2026, selling an estimated $159K and leaving 6,122 shares worth $2.58M. The position accounts for 1.54% of the portfolio, ranked #16.
Davis Capital Management first reported a position in AMGN in Q1 2020 and has held it in 13 quarters since. 1,149 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Davis Capital Management held 6,122 shares of Amgen worth $2.58M as of Q3 2026.
- Davis Capital Management sold 399 Amgen shares in Q3 2026, an estimated $159K.
- Amgen made up 1.54% of Davis Capital Management's portfolio in Q3 2026, its #16 holding.
- Davis Capital Management first reported a position in Amgen in Q1 2020 and has held it in 13 quarters since.
- 1,149 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.